Why Some Beauty Houses Last a Century and Others Get Sold for Parts

Beiersdorf has been selling Nivea Creme in a round blue tin since 1925. Shiseido was founded in 1872. Neutrogena, Aveeno and Listerine were inside Johnson and Johnson for decades before being spun into Kenvue in 2023, and Kenvue was then sold to Kimberly-Clark in a deal worth 48.7 billion dollars. Three different endings for three sets of very old brands.

For anyone building a small brand the interesting question is not which of them made more money. It is what the survivors did that the sold-for-parts ones did not, and how much of it happened on the outside of the product.

The tin nobody was allowed to redesign

Nivea's blue tin is the clearest case in the industry of packaging as the brand rather than packaging as the wrapper. The formula inside has been reformulated many times. The colour, the shape and the weight of the tin have barely moved in a century, and a customer in any country can identify it across a shop floor without reading a word.

That is an asset that cannot be bought quickly. It was built by refusing to modernise the one thing everybody recognises, while changing almost everything else. Beiersdorf still launches into new categories under that name, including a recent Nivea serum built on an epigenetics ingredient aimed at the longevity category, and the tin gives every launch a hundred years of borrowed familiarity.

What a portfolio is actually for

Large houses do not run one brand at many price points. They run many brands at one price point each, because a single brand that stretches from pharmacy to prestige convinces nobody at either end.

Shiseido has bought its way into new positions rather than stretching the parent name, picking up microbiome skincare through its acquisition of Gallinee. The same logic runs through every large group: a new position usually arrives as a new brand with its own packaging language, because the packaging is what tells a customer which shelf they are standing at.

Where the sold-for-parts ones differed

The brands that end up detached and sold are rarely bad brands. Neutrogena and Aveeno are strong names with real customer loyalty. What they lacked was strategic fit with a parent that had become a pharmaceutical company, and a corporate structure has nothing to do with whether a face wash is good.

The lesson that transfers down to a small brand is narrower and more useful. A brand survives a change of owner when its identity lives in things a buyer can acquire and continue: a recognisable pack, a consistent format, a customer who can find it without help. It does not survive when its identity lived in a marketing budget.

What a small brand can copy

• Pick one visual element you will not change. A colour, a silhouette, a closure. Change everything else freely and leave that alone for years.
• Do not stretch one name across price tiers. If you want a cheaper line, give it its own packaging language and let it look cheaper on purpose.
• Reformulate inside the same pack rather than relaunching the pack. Customers forgive a better formula. They struggle to find a bottle that moved.
• Build recognition into the silhouette rather than the label. Labels get redesigned by every new agency. A shape survives them.

None of that requires scale. It requires deciding early which part of the pack is permanent, and then being boring about it for longer than feels comfortable.